Key statistics
As of last trade, Neuraxis Inc (NRXS:ASQ) traded at 2.95, 63.61% above the 52 week low of 1.80 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.60 |
---|---|
High | 3.13 |
Low | 2.59 |
Bid | 2.86 |
Offer | 3.15 |
Previous close | 2.60 |
Average volume | 7.65k |
---|---|
Shares outstanding | 6.84m |
Free float | 3.34m |
P/E (TTM) | -- |
Market cap | 17.79m USD |
EPS (TTM) | -3.09 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 17:42 BST.
More ▼
- NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
- NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
- NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
- NeurAxis Reports Second Quarter 2024 Financial Results
- NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
- NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
- NeurAxis Reports First Quarter 2024 Financial Results
- NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
- NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
- NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
More ▼